1C ardo E, Monros E, Colome C, et al. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and Vitamin status [J] .J Child Neurol,2000,15(5) :295-298.
3Hankey GJ, Eikelboom JW. Homocysteine levels in patients with stroke: clinical relevance and therapeutic implications[J]. CNS Drugs,2001,15(6):437-443.
4Frosst P, Blotm HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase[ J]. Nat Genet, 1995,10(1): 111-113.
5Pezzini A, Del Zotto E, Archetti S, et al. Hasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke[J]. Stroke,2002,33(3) :664-669.
7Eikelboom JW, Hankey GJ, Anand SS, et al. Association between high homocysteine and ischemic stroke due to large-and small-artery disease but not other etiologic subtypes of ischemic stroke[J] .Stroke,2000,31(5): 1069-1075.
8You JH, Choi GD, Kang SS. Pathogenicity of thennolabile methylenetetrahydrofolate reductnse for vascular dementia[J]. Arterioscler-Thromb-Vasc-Biol,2000,20(8): 1921-1925.
9Candito M, Bedoucha P, Mahagne M H, et al. Total plasma homocystein detennination with liquid chromatography before and after methionine loading. Results in cerebrovascular disease[J]. J Chromatogr B Biomed Sci Appl, 1997,692(1) :213-216.
10Sacco tL, Roberts JK, Jacobs BS, et al. Homocysteine as a risk factor for ischemic stroke;an epidemiological story in evolution [J]. Nuroepidemiology, 1998,17(4): 167-173.
